发明名称 ANTHRANILIC ACID AMIDES AND PHARMACEUTICAL USE THEREOF.
摘要 <p>The invention relates to anthranilic acid amide derivatives of formula (I), wherein Ar is represented by the subformula (Ia), wherein Ra represents H or lower alkyl, and R1 represents H or perfluoro lower alkyl, R2 represents H, halogen, C2-C7alkyl, C2-C7alkenyl or lower aklynyl; or Ar is represented by the subformula (Ib) and R1 represents perfluoro lower alkyl, and R2 represents bromo, iodo, C2-C7alkyl, C2-C7alkenyl or lower alkynyl, or R1 represents H, and R2 represents fluoro, bromo, iodo, ethyl, C5-C7alkyl, C2-C7alkenyl or lower alkynyl; to N-oxides and tautomers thereof, and to salts of such anthranilic acid amides, its N-oxides and tautomers; to processes for their preparation; to their application in the treatment of the human or animal body, to the use thereof - alone or in combination with one or more other pharmaceutically active compounds - for the treatment especially of a neoplastic disease, such as a tumor disease, of retinopathy or age-related macular degeneration; to a method for the treatment of such diseases in animals; and to the use of such a compound - alone or in combination with one or more other pharmaceutically active compounds - for the manufacture of a pharmaceutical preparation for the treatment of a neoplastic disease, of retinopathy or age-related macular degeneration.</p>
申请公布号 MXPA04004390(A) 申请公布日期 2005.05.16
申请号 MX2004PA04390 申请日期 2002.11.07
申请人 NOVARTIS AG 发明人 PASCAL FURET
分类号 A61K31/166;A61K31/4409;A61P3/10;A61P9/10;A61P11/06;A61P15/00;A61P17/06;A61P19/02;A61P27/00;A61P27/06;A61P29/00;A61P35/00;A61P35/02;C07C231/12;C07C237/40;C07D213/38;C07D213/89;(IPC1-7):A61K31/165;A61K31/44 主分类号 A61K31/166
代理机构 代理人
主权项
地址